SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017137
Filing Date
2022-08-12
Accepted
2022-08-12 16:31:37
Documents
61
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-20220630.htm   iXBRL 10-Q 1637529
2 EX-10.1 clsd-ex10_1.htm EX-10.1 20939
3 EX-31.1 clsd-ex31_1.htm EX-31.1 17894
4 EX-31.2 clsd-ex31_2.htm EX-31.2 17548
5 EX-32.1 clsd-ex32_1.htm EX-32.1 11984
6 GRAPHIC img140554452_0.jpg GRAPHIC 54502
  Complete submission text file 0000950170-22-017137.txt   6076877

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clsd-20220630_cal.xml EX-101.CAL 32093
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clsd-20220630_def.xml EX-101.DEF 167981
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsd-20220630_lab.xml EX-101.LAB 373732
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsd-20220630.xsd EX-101.SCH 45218
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsd-20220630_pre.xml EX-101.PRE 275882
55 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20220630_htm.xml XML 979037
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 221160641
SIC: 2834 Pharmaceutical Preparations